A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar

Clinical trial NCT01197911 · COMPLETED

Trial details

NCT number: NCT01197911
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2010-09-01
Primary completion: 2011-08-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.